- Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
-
Jung CY, Antonia SJ
- KMID: 2420589
- Tuberc Respir Dis.
- 2018 Jan;81(1):29-41.
- doi: 10.4046/trd.2017.0120
Lung cancer is one of the most commonly diagnosed cancers and the leading cause of cancer-related deaths worldwide. Although progress in the treatment of advanced non-small cell lung cancer (NSCLC)... -
- CITED
-
- Close
- SHARE
-
- Close
